Baxter, Laboratoire Aguettant sign global pact for parenteral nutrition trace elements

Baxter International Inc.,  a global, diversified healthcare compan, and Laboratoire Aguettant SAS, Lyon, France, have signed an exclusive global licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy. The collaboration allows Baxter to augment its leading PN portfolio, currently available in more than 90 countries, with essential trace elements.

Parenteral nutrition is an intravenous (IV) therapy, which may include a balance of protein, carbohydrates, lipids (fats), electrolytes, vitamins and trace elements for patients who cannot ingest food orally or enterally (tube-fed).